Apothecary Nad+ recalls
The FDA has published 1 recall involving Apothecary Nad+ since 2026. The latest was reported on 14 Oct 2026. Most were for sterility. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls1since 2026
Last 12 months1reported
Class I00% of total
Ongoing1latest 14 Oct 2026
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 100%Class III 0 0%
Why apothecary nad+ is recalled
Companies
By year
Ongoing apothecary nad+ recalls
1 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Apothecary NAD+ Injection 200 mg/mL Sterile Multi-Dose Vial recalled | Apothecary Pharma | Sterility | Nationwide |
All apothecary nad+ recalls, newest first
1 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Apothecary NAD+ Injection 200 mg/mL Sterile Multi-Dose Vial recalled | Apothecary Pharma | Sterility | Nationwide |
Should you stop taking Apothecary Nad+?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.